Thermo Fisher Scientific Inc. (NYSE:TMO) reported mixed third-quarter financial results and lowered its FY23 guidance.
Thermo Fisher Scientific posted adjusted earnings of $5.69 per share, versus expectations of $5.61 per share. The company’s sales came in at $10.57 billion, compared to estimates of $10.59 billion.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased